ReposiTrak Inc. (NYSE:TRAK – Get Free Report) CEO Randall Fields sold 7,500 shares of the business’s stock in a transaction dated Monday, September 8th. The shares were sold at an average price of $16.06, for a total transaction of $120,450.00. Following the completion of the sale, the chief executive officer owned 79,500 shares of the company’s stock, valued at approximately $1,276,770. This represents a 8.62% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link.
ReposiTrak Stock Performance
NYSE TRAK opened at $16.98 on Wednesday. The company has a market capitalization of $310.39 million, a P/E ratio of 49.94 and a beta of 0.47. The company’s 50 day simple moving average is $17.44. The company has a current ratio of 6.03, a quick ratio of 6.03 and a debt-to-equity ratio of 0.01. ReposiTrak Inc. has a 52-week low of $15.12 and a 52-week high of $25.01.
ReposiTrak Cuts Dividend
The business also recently announced a quarterly dividend, which was paid on Thursday, August 14th. Shareholders of record on Monday, June 30th were given a dividend of $0.0182 per share. This represents a $0.07 annualized dividend and a yield of 0.4%. The ex-dividend date of this dividend was Monday, June 30th. ReposiTrak’s dividend payout ratio (DPR) is 20.59%.
Institutional Investors Weigh In On ReposiTrak
Analyst Ratings Changes
Separately, Wall Street Zen raised ReposiTrak from a “hold” rating to a “buy” rating in a research report on Thursday, May 22nd.
Get Our Latest Analysis on TRAK
ReposiTrak Company Profile
Park City Group, Inc, a software-as-a-service provider, designs, develops, and markets proprietary software products in North America. The company offers ReposiTrak MarketPlace, a supplier discovery and B2B e-commerce solution; ReposiTrak Compliance and Food Safety solutions, which reduces potential regulatory and legal risk from their supply chain partners; and ReposiTrak Supply Chain solutions that enables customers to manage relationships with suppliers.
Featured Stories
- Five stocks we like better than ReposiTrak
- Are Penny Stocks a Good Fit for Your Portfolio?
- Is Qualcomm Tesla’s Next Rival in Autonomous Driving?
- There Are Different Types of Stock To Invest In
- 3 Under-the-Radar Biotechs Under $5 That Could Soar 200%
- Russell 2000 Index, How Investors Use it For Profitable Trading
- The Quiet Before the Catalyst: Vertical Aerospace’s Next Move
Receive News & Ratings for ReposiTrak Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ReposiTrak and related companies with MarketBeat.com's FREE daily email newsletter.